Founded 2001 | ||
 | ||
Profiles | ||
Proteintech group antibodies for scientists by scientists
Proteintech Group is a multinational biotechnology company with offices based in Chicago, Europe (Manchester, UK) and China (Wuhan). Founded as a start-up company in Chicago in 2002, it supplies polyclonal and monoclonal antibodies to the medical and life science research community.
Contents
- Proteintech group antibodies for scientists by scientists
- Proteintech antibodies used in research
- References
Proteintech produces all of its antibodies therefore does not ‘resell’ antibodies, i.e. it does not source its antibodies from other companies. Proteintech currently have 11,000 pre-made primary antibodies for sale.
Proteintech antibodies used in research
Proteintech Group’s antibodies have been successful in several research areas. For example, the antibody against TAR DNA-binding protein 43 has featured in many publications investigating its role in many neuropathologies including: ALS, FTLD, Alzheimer's disease,. Parkinson's disease Lewy body disease Huntington's Disease and Machado-Joseph disease Proteintech was also the first company to provide a commercially available FKBPL antibody. This has been most notably used in a study to determine the response of breast cancer patients to the drug Tamoxifen.